Episode 4 - Expert-Guided Strategies to Improve Recognition, Diagnosis, and Treatment of PH Associated with ILD - Part 1: Overview and Screening Strategies for PH-ILD

Pulmonary hypertension among patients with interstitial lung diseases (PH-ILD) is currently under-recognized and is associated with increased morbidity, mortality, and healthcare burden. Individualized treatment approaches need to be incorporated in the continuum of care to improve early detection, accurate diagnosis, and improved patient outcomes. In this podcast series, Drs. Jean Elwing, Steven Nathan, and Ioana Preston inform and guide on recent insights to screen for, detect, and accurately diagnose PH-ILD. This on-demand audio presentation uses didactic, case-based, and conversational formats to provide practical guidance and increase familiarity with the latest best-practice approaches for treatment and management of PH-ILD, to ultimately improve the quality of life of patients.

Launch Date: October 14, 2024

Release Date: October 7, 2024

Expiration Date: September 30, 2025

FACULTY

Steven Nathan, MD

Medical Director, Advanced Lung Disease and Transplant Program

Inova Fairfax Hospital

Jean Elwing, MD

Professor of Medicine

Director, Pulmonary Hypertension Program

University of Cincinnati

Ioana Preston, MD

Associate Professor of Medicine

Tufts University School of Medicine

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.

https://www.practicepointcme.com/CMEHome/expert-guided-strategies-to-improve-recognition-diagnosis-and-treatment-of-ph-associated-with-ild-1